Navigation Links
Picking the Right Toys Isn't Child's Play
Date:12/17/2007

Find items or activities that stretch youngsters' creativity and forge bonds with others, experts say

SUNDAY, Dec. 16 (HealthDay News) -- When you're Christmas shopping for toys, ignore the latest fad, experts say. Instead, choose toys that promote healthy childhood development and reinforce personal relationships.

"It's important to look for toys that allow for creativity, imagination, manipulation, and change. If a toy is static and doesn't promote those concepts, it will probably end up in the corner," Roger Ideishi, professor of occupational therapy at the University of the Sciences, Philadelphia, said in a prepared statement.

"Parents often feel like they have to rush out and get 'the toy of the moment,' " noted Paula Kramer, chair and professor of occupational therapy at the university. "These toys may be interesting, unique and novel, but they're not always the best thing for the child or the toy with the longest life."

When selecting a toy, consider the child's specific needs and interests. Look for toys that promote mental and physical development, such as building blocks/sets that help build fine motor skills and creativity.

Video games that encourage physical or mental activity may be good choices. And parents shouldn't hesitate to play these kinds of video games with their children.

"It's just like anything else. If your child asks you to do some coloring with them, you usually do it even if you don't want to, because the child seeks that interaction. It's the same thing when a child asks you to play a video game," Kramer said.

When selecting any kind of toy, it's important that they match the child's abilities.

"Look for toys that are either at their child's ability, or just above it. Then, they will grow with the toy and get more of a challenge from it. The toys that don't engage the children or speak to their imaginations and interests tend to just stay on the shelf," Kra
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Paragon Technologies SI Systems Brand Awarded A $1.0 Million System Expansion Contract for an Automated Light-Picking System
2. Stressed-Out Moms Carry Babies on the Right
3. Bright tumors, dim prospects
4. Quality Innovators to Network in Atlanta Sept. 19-21: Learn from Those Who Got It Right
5. Right breakfast bread keeps blood sugar in check all day
6. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
7. Experts Agree. Ohios Technology Investment Future Looks Bright
8. L.A. Playwright Creates an Enormous Wave with His New Book, Touch the Ocean
9. Civil Rights and Medical Leaders Call for Social Justice in Health Care
10. Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
11. New Report Says Health Courts Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...on models are enhanced by taking into account risk...ity, according to research teams led by epidemiolo...ncer Center in two complementary papers appearing ...rch . , In the first study to focus on African-A...n increased exposure to certain risks. Based upon ...
(Date:9/4/2008)...wswire/ -- A groundbreaking program,dealing with t...atus of,men, their shorter life spans, unmet gende...ke place Wednesday, September 17 at White Plains,H... of the Westchester,medical and psychiatric societ... and Lionel Tiger, Ph.D., Dr. Legatto, an interna...
(Date:9/4/2008)...ivate Medicare Advantage (MA) plans will be paid a...ompared to what the same enrollee would have cost ...m, according to a new report from The Commonwealth... mandated by the Medicare Improvements for Patient...take effect beginning in 2010 had been fully in p...
(Date:9/4/2008)...ns may be shortchanging their golden years by tapp...University of Illinois expert who has studied the ... , More than three of every four Americans trim ...laiming benefits early, a choice many might forego...nd consequences, law professor Richard L. Kaplan s...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3
... levels of stress experienced by children may hamp...n suffering from post-traumatic// stress disorder ... memory and emotion had become smaller in size. C...stress and anxiety when their hippocampus is shrun...
...in, say researchers at the Stanford University Sch...spital. The researchers found that children with p...he stress hormone cortisol were likely to experien...n structure important in memory processing and emo...
...on for health professionals must include teaching ...//cancer about sex, cancer experts say. Sexuality... want to discuss with their doctor or member of th...rn of the Cancer Council Victoria, and Dr Annette ...
...hat a new technique safely and effectively removes...t risk for pulmonary embolism and disability. Th...n to have a positive impact on patients’ quality o...in and swelling, as well as greatly improving thei...
Other Medicine News:Health News:Child Brain Likely To Be Harmed By Stress 2Health News:Severe PTSD Damages Children's Brains: Study 2Health News:Severe PTSD Damages Children's Brains: Study 3Health News:Sex After Cancer 2Health News:DVT Treatment Vacuums Away Blood Clots – Prevents Disabilit 2
(Date:9/4/2008)...- Southern Research Institute,today announced that...ted,the organization to participate in the newly-f...Network (MLPCN). The MLPCN -- a collaborative,rese... Program which is,designed to benefit human health... and validate future targets for drug discovery., ...
(Date:9/4/2008)...l activity and favorable safety .../- Idenix,Pharmaceuticals, ... engaged,in the discovery and development of drugs...ious diseases, today announced that it has complet... non-nucleoside reverse,transcriptase inhibitor (N...
(Date:9/3/2008)...ldren Studied. Wrong,Conclusions Reached., NIXA, ...for Disease,Control and Prevention (CDC) study rel...R vaccine and autism. The National Autism Associat...he growing public concern over a,vaccine-autism co...esign,and methodology., For years, parents have c...
(Date:9/3/2008)...sease Awareness Month, CHARLOTTESVILLE, Va., Sept... a clinical-stage drug-development company commerc...cal needs, announced today that it has begun,to en...s lead drug,candidate trans sodium crocetinate (TS...caltrials.gov Website, is investigating TSC as a t...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Heat stress influences low conception of dairy herds 288 1Heat stress influences low conception of dairy herds 288 2Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 1Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 2Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 3Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 4Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision 3B Believes Offer Significantly Undervalues Company 666 5Youth Drug Use at a Five Year Low New Survey Shows 662 1Youth Drug Use at a Five Year Low New Survey Shows 662 2Youth Drug Use at a Five Year Low New Survey Shows 662 3Securians Minnesota Life Continues to Climb Group Life Rankings 658 1
...tudy Fails to Meet Primary Endpoint of Improvement... 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics...H, the Company,s pivotal Phase 3 study of Efaproxy...y (WBRT) in women,with brain metastases originatin...its primary endpoint of demonstrating a,statistica...
...SAN DIEGO, June 20, 2007 /PRNewswire-FirstCall/ --...l company committed to,the discovery, development ...reatment of hepatitis and cancer, announced today ...inical development as an,orally-administered direc... C virus (HCV) infection. , "We have identified a ...
Other Medicine Technology:Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 2Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 3Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 4Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 5Allos Therapeutics Reports Results for Phase 3 Enrich Study of,Efaproxyn in Women With Brain Metastases Originating From Breast,Cancer 6Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 2Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 3Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule,Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for,Clinical Development in Chronic Hepatitis C Virus Infection 4
Hudson-Downs Burr
McKenzie Perforator Drill
Cushing Perforator Drill
Self retaining brain retractor.
Medicine Products: